Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas

NCT01088815 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Cancer

Interventions

DRUG: Gemcitabine, nab-Paclitaxel, GDC-0449

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]
[object Object]
[object Object]